Clinical Trials Directory

Trials / Conditions / Rivaroxaban

Rivaroxaban

11 registered clinical trials studyying Rivaroxaban — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingExcretion of Rivaroxaban in Human Breast Milk
NCT06831474
Thomas Jefferson UniversityPhase 1
RecruitingModel-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasak
NCT06978439
Children's Hospital of Fudan UniversityPhase 4
Not Yet RecruitingImapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study
NCT05764356
Peking University First Hospital—
RecruitingPharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years
NCT06993636
Children's Hospital of Fudan University—
UnknownRivaroxaban or Aspirin in Patients With CHD & GD Undergoing PCI
NCT04805710
Shenyang Northern HospitalPhase 4
UnknownVenous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin
NCT04999176
André Luiz Malavasi Longo de OliveiraPhase 3
UnknownRivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports
NCT04309240
LiuZhou People's HospitalPhase 3
UnknownRivaroxaban in Elderly NVAF Patients With or Without Renal Impairment
NCT04096547
Samsung Medical Center—
UnknownA Trial of Rivaroxaban Versus Warfarin in Dissolving Left Atrial Appendage Thrombus in Patients With Atrial Fi
NCT03792152
The Second Affiliated Hospital of Chongqing Medical UniversityN/A
UnknownImpact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants
NCT03161496
Cui Yimin—
CompletedRivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer
NCT01989845
Seoul National University HospitalPhase 4